A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial.

RPEP-100952025Baretti, Marina; Kirk, Allison M; Ladle, Brian H; Kamdar, Zeal; Bendinelli, Kayla J; Ho, Won Jin; Adhikari, Samir; Clark, Nicholas A; Sundararaman, Balaji; Wang, Hao; Kung, Heng-Chung; Hernandez, Jeric; Qi, Hanfei; Shin, Sarah M; Hernandez, Alexei; Nakazawa, Mari; Schattgen, Stefan A; Crawford, Jeremy Chase; Furth, Mark; Anders, Robert A; Thoburn, Chris; Zaidi, Neeha; Huff, Amanda L; Nauroth, Julie; Jaffee, Elizabeth; Pogorelyy, Mikhail V; Thomas, Paul G; Yarchoan, Mark

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial.

Nature medicine, 31(12), 4246-4255

View on PubMed ↗Publisher’s paper ↗

Citation

Baretti, Marina; Kirk, Allison M; Ladle, Brian H; Kamdar, Zeal; Bendinelli, Kayla J; Ho, Won Jin; Adhikari, Samir; Clark, Nicholas A; Sundararaman, Balaji; Wang, Hao; Kung, Heng-Chung; Hernandez, Jeric; Qi, Hanfei; Shin, Sarah M; Hernandez, Alexei; Nakazawa, Mari; Schattgen, Stefan A; Crawford, Jeremy Chase; Furth, Mark; Anders, Robert A; Thoburn, Chris; Zaidi, Neeha; Huff, Amanda L; Nauroth, Julie; Jaffee, Elizabeth; Pogorelyy, Mikhail V; Thomas, Paul G; Yarchoan, Mark. (2025). A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial.. Nature medicine, 31(12), 4246-4255. https://doi.org/10.1038/s41591-025-03995-y